255 related articles for article (PubMed ID: 22426112)
21. The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses.
Vang T; Landskron J; Viken MK; Oberprieler N; Torgersen KM; Mustelin T; Tasken K; Tautz L; Rickert RC; Lie BA
Hum Immunol; 2013 May; 74(5):574-85. PubMed ID: 23333624
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266W.
Liu J; Chen M; Li R; Yang F; Shi X; Zhu L; Wang HM; Yao W; Liu Q; Meng FG; Sun JP; Pang Q; Yu X
PLoS One; 2012; 7(8):e43631. PubMed ID: 22952725
[TBL] [Abstract][Full Text] [Related]
23. SH3-domain mutations selectively disrupt Csk homodimerization or PTPN22 binding.
Brian BF; Sjaastad FV; Freedman TS
Sci Rep; 2022 Apr; 12(1):5875. PubMed ID: 35393453
[TBL] [Abstract][Full Text] [Related]
24. Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes.
Cloutier JF; Chow LM; Veillette A
Mol Cell Biol; 1995 Nov; 15(11):5937-44. PubMed ID: 7565746
[TBL] [Abstract][Full Text] [Related]
25. Csk is constitutively associated with a 60-kDa tyrosine-phosphorylated protein in human T cells.
Catipović B; Schneck JP; Brummet ME; Marsh DG; Rafnar T
J Biol Chem; 1996 Apr; 271(16):9698-703. PubMed ID: 8621646
[TBL] [Abstract][Full Text] [Related]
26. The effects of membrane compartmentalization of csk on TCR signaling.
Otáhal P; Pata S; Angelisová P; Hořejší V; Brdička T
Biochim Biophys Acta; 2011 Feb; 1813(2):367-76. PubMed ID: 21167217
[TBL] [Abstract][Full Text] [Related]
27. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation.
Hill RJ; Zozulya S; Lu YL; Ward K; Gishizky M; Jallal B
Exp Hematol; 2002 Mar; 30(3):237-44. PubMed ID: 11882361
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of C-terminal Src kinase by siRNA-mediated RNA interference augments T cell receptor signaling in mature T cells.
Vang T; Abrahamsen H; Myklebust S; Enserink J; Prydz H; Mustelin T; Amarzguioui M; Tasken K
Eur J Immunol; 2004 Aug; 34(8):2191-9. PubMed ID: 15259016
[TBL] [Abstract][Full Text] [Related]
29. Human c-SRC kinase (CSK) overexpression makes T cells dummy.
Inderberg EM; Mensali N; Oksvold MP; Fallang LE; Fåne A; Skorstad G; Stenvik GE; Progida C; Bakke O; Kvalheim G; Myklebust JH; Wälchli S
Cancer Immunol Immunother; 2018 Apr; 67(4):525-536. PubMed ID: 29248956
[TBL] [Abstract][Full Text] [Related]
30. Functional analysis of Csk in signal transduction through the B-cell antigen receptor.
Hata A; Sabe H; Kurosaki T; Takata M; Hanafusa H
Mol Cell Biol; 1994 Nov; 14(11):7306-13. PubMed ID: 7935444
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.
Börner C; Smida M; Höllt V; Schraven B; Kraus J
J Biol Chem; 2009 Dec; 284(51):35450-60. PubMed ID: 19858202
[TBL] [Abstract][Full Text] [Related]
32. Functional and physical interaction of protein-tyrosine kinases Fyn and Csk in the T-cell signaling system.
Takeuchi M; Kuramochi S; Fusaki N; Nada S; Kawamura-Tsuzuku J; Matsuda S; Semba K; Toyoshima K; Okada M; Yamamoto T
J Biol Chem; 1993 Dec; 268(36):27413-9. PubMed ID: 8262983
[TBL] [Abstract][Full Text] [Related]
33. Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.
Rahmouni S; Vang T; Alonso A; Williams S; van Stipdonk M; Soncini C; Moutschen M; Schoenberger SP; Mustelin T
Mol Cell Biol; 2005 Mar; 25(6):2227-41. PubMed ID: 15743820
[TBL] [Abstract][Full Text] [Related]
34. A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling.
Nika K; Tautz L; Arimura Y; Vang T; Williams S; Mustelin T
J Biol Chem; 2007 Dec; 282(49):36000-9. PubMed ID: 17897955
[TBL] [Abstract][Full Text] [Related]
35. Novel tools to dissect the dynamic regulation of TCR signaling by the kinase Csk and the phosphatase CD45.
Tan YX; Zikherman J; Weiss A
Cold Spring Harb Symp Quant Biol; 2013; 78():131-139. PubMed ID: 24100586
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of Csk-mediated down-regulation of Src family tyrosine kinases in epidermal growth factor signaling.
Matsuoka H; Nada S; Okada M
J Biol Chem; 2004 Feb; 279(7):5975-83. PubMed ID: 14613929
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acids.
Vang T; Xie Y; Liu WH; Vidović D; Liu Y; Wu S; Smith DH; Rinderspacher A; Chung C; Gong G; Mustelin T; Landry DW; Rickert RC; Schürer SC; Deng SX; Tautz L
J Med Chem; 2011 Jan; 54(2):562-71. PubMed ID: 21190368
[TBL] [Abstract][Full Text] [Related]
38. Small molecule inhibition of Csk alters affinity recognition by T cells.
Manz BN; Tan YX; Courtney AH; Rutaganira F; Palmer E; Shokat KM; Weiss A
Elife; 2015 Aug; 4():. PubMed ID: 26302204
[TBL] [Abstract][Full Text] [Related]
39. Autonomous maturation of alpha/beta T lineage cells in the absence of COOH-terminal Src kinase (Csk).
Schmedt C; Tarakhovsky A
J Exp Med; 2001 Apr; 193(7):815-26. PubMed ID: 11283154
[TBL] [Abstract][Full Text] [Related]
40. CSK associates with the TCR zeta and epsilon chains via its SH2 domain; a mechanism for turning off TCR signaling.
Catipović B
Lijec Vjesn; 1996; 118(11-12):264-71. PubMed ID: 9172452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
